Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07129590 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Trauma-Informed Care for Smoking Cessation for Pregnancy

StatusRecruiting
PhaseNot applicable
Started2025-11-19
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later Jul 31, 2026 → Dec 31, 2026
See other at-risk trials from University of California, San Francisco

Amendment history

2026-09-04
notable
Study Status v5
Primary completion pushed: 2026-07-31 → 2026-12-31
Completion pushed: 2026-07-31 → 2026-12-31
2026-04-20
minor
Study Status, Eligibility v4
Primary completion date2026-03-31→2026-07-31
Completion date2026-03-31→2026-07-31
Eligibility criteria-92 characters
Inclusion Criteria: Clinician Eligibility Criteria (Aims 1 - 3): In Aims 1-3, will be recruiting clinicians working in the Obstetrics, Midwifery, and Gynecology Clinic (5M) safety-netour clinic and the UCSF Community and Clinical Research Center (ZSFG)sites. Nurse practitioner, physician assistant, nurse-midwife, or medical doctor, registered nurse, clinical pharmacist, behavioral health professional, social worker, or any other healthcare professional caring for pregnant patient-participants. Age ≥ 18 years ol [...] iteria (Aim 1): In Aim 1, will be recruiting pregnant women receiving care at the 5M [...] [...]
2025-12-05
minor
Study Status, Eligibility v3
Eligibility criteria+649 characters
Inclusion Criteria: Clinician Eligibility Criteria (Aims 1 - 3): In AimAims 1-3, will be recruiting clinicians working in the Obstetrics, Midwifery, and Gynecology Clinic (5M) safety-net clinic and the UCSF Community and Clinical Research Center (ZSFG). Nurse practitioner, physician assistant, nurse-midwife, or [...] e ≥ 18 years old. Patient-participant Eligibility Criteria (AimsAim 1 & 3): In Aim 1, will be recruiting pregnant women receiving care at the 5M safety-net clinic who are actively smoking and have histories of trauma (ages 18+) Currently smoking (ever smoked 100 cigarettes in their lifet [...] [...]
2025-11-19
notable
Not Yet Recruiting→Recruiting Study Status, Study Description, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2025-11-15→confirmed 2025-11-19
Study description+50 characters
This study is currently enrolling for Aim 1 only. Study Objectives: Aim 1: Assess barriers to successful mater [...]
Study sitesdetails revised at 1 of 1 site
2025-10-29
minor
Study Status, Contacts/Locations v1
Start date2025-09-01→2025-11-15
Study sitescontacts updated at 1 of 1 site
2025-08-11
minor
Original filing
Trauma-informed approaches have been shown to support recovery from other substance use disorders and involve four key elements: (1) Realizing the prevalence of trauma and pathways to recovery, (2) Recognizing symptoms of trauma, (3) Responding by embedding knowledge of trauma into practices and policies and (4) Resisting re-traumatization (the 4Rs). In close partnership with Breathe California and a public safety-net clinic in San Francisco that serves primarily racial and ethnic minoritized (REM) pregnant women, the 4Rs along with the Ask, Advise, Assess, Assist and Arrange (the 5As) evidence-based intervention for tobacco cessation that is delivered by health care professionals and is a US Public Health Services clinical practice guideline for treating tobacco will be used to create and implement a smoking cessation intervention for pregnant women with experiences of trauma.
Trial Details
NCT Number NCT07129590
Lead Sponsor University of California, San Francisco
Collaborators: Tobacco Related Disease Research Program
Conditions Smoking Cessation, Tobacco Smoking, Tobacco Use Cessation, Smoking Reduction, Smoking, Cigarette, Trauma, Psychological, Trauma and Stressor Related Disorders
Enrollment 20 participants
Start Date 2025-11-19
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-09-10